Our Target Markets – Other Applications

In addition to the treatment of venous ulcers and pressure ulcers, Phoenix Eagle intends to clinically investigate the use of OPAL Products in the treatment of other types of wounds, including burns, and a range of other skin conditions.

We believe that once the efficacy of OPAL A and other OPAL Products has been clinically validated, their effectiveness in healing a range of cosmetic imperfections and problems will also be recognised and will be able to be demonstrated in an appropriately designed clinical trial. The consequence will be acceptance of the OPAL Products as having ingredients that improve the quality of facial skin and the creation of significant opportunities in the global cosmetics market.

Our Australian licensee, Health Focus Products Australia Pty Ltd (HFPA), has introduced the first of three planned cosmetic brands into the Australian marketplace.